Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RPRX
#500
Royalty Pharma plc Class A Ordinary Shares
46.210
0
+2.45%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+2.45%
Monthly Change
+13.99%
6 month change
+24.02%
Year Change
+24.02%
Previous Close
45.105
0
Open
46.210
0
Bid
Ask
Low
46.210
0
High
46.210
0
Volume
225
Markets
US Stock Market
Healthcare
RPRX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
0.15
0.68
0.76
0.8
0.84
0.88
1.54
Dividend yield %
0.3
1.71
1.93
2.83
3.29
2.28
15.42
Payout ratio %
9.34
66.62
760
31.62
43.98
49.44
566.71
News
TD Cowen raises Royalty Pharma stock price target to $50 on growth
Royalty Pharma stock hits 52-week high at 46.14 USD
Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript
Royalty Pharma stock hits 52-week high at 44.94 USD
Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion
Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q4 Earnings
Royalty Pharma earnings beat by $0.22, revenue topped estimates
McDonald’s, Cisco, Shopify, and more set to report earnings Wednesday
Royalty Pharma earnings in focus after $4.7B deal spree